2019 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
His primary areas of investigation include Kidney transplantation, Transplantation, Surgery, Internal medicine and Intensive care medicine. His Kidney transplantation research is multidisciplinary, incorporating elements of Nephrology, Cohort study, Emergency medicine, Cohort and Plasmapheresis. His Transplantation study combines topics from a wide range of disciplines, such as Lower risk, Hepatitis C, Immunology, Proportional hazards model and Dialysis.
His studies in Surgery integrate themes in fields like Urinary system, Kidney and Donation. The study of Internal medicine is intertwined with the study of Gastroenterology in a number of ways. His Intensive care medicine research incorporates themes from MEDLINE and Disease, End stage renal disease.
Internal medicine, Kidney transplantation, Transplantation, Surgery and Hazard ratio are his primary areas of study. His study on Internal medicine is mostly dedicated to connecting different topics, such as Gastroenterology. His Kidney transplantation research includes elements of Immunology, Dialysis, Donation and Intensive care medicine.
His Transplantation research is multidisciplinary, incorporating perspectives in Incidence, Retrospective cohort study, Kidney disease and Cohort. His Surgery study frequently involves adjacent topics like Urinary system. The study incorporates disciplines such as Renal function and Urology in addition to Kidney.
The scientist’s investigation covers issues in Internal medicine, Transplantation, Kidney transplantation, Proportional hazards model and Hazard ratio. Kidney, Prospective cohort study, Kidney transplant, Immunosuppression and Dialysis are the subjects of his Internal medicine studies. While the research belongs to areas of Transplantation, he spends his time largely on the problem of Cohort, intersecting his research to questions surrounding Retrospective cohort study.
His Kidney transplantation research incorporates elements of Pandemic, Health care, Gerontology and Urology. Dorry L. Segev works mostly in the field of Proportional hazards model, limiting it down to concerns involving Gastroenterology and, occasionally, Lower risk. His studies deal with areas such as Body mass index, Cumulative incidence and Donor pool as well as Hazard ratio.
Dorry L. Segev focuses on Internal medicine, Transplantation, Kidney transplantation, Coronavirus disease 2019 and Incidence. His work on Internal medicine deals in particular with Prospective cohort study, Proportional hazards model, Hazard ratio, Cohort and Confidence interval. His work carried out in the field of Transplantation brings together such families of science as Response rate and Kidney disease.
As a part of the same scientific family, Dorry L. Segev mostly works in the field of Response rate, focusing on Kidney and, on occasion, Thrombosis, Venous thrombosis and Surgery. His research integrates issues of Gerontology, MEDLINE, Intensive care medicine, Stressor and Dialysis in his study of Kidney transplantation. Dorry L. Segev works mostly in the field of Incidence, limiting it down to topics relating to Epidemiology and, in certain cases, Emergency medicine and Immunosuppression.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Frailty as a Predictor of Surgical Outcomes in Older Patients
Martin A. Makary;Dorry L. Segev;Peter J. Pronovost;Dora Syin.
Journal of The American College of Surgeons (2010)
Risk of end-stage renal disease following live kidney donation
Abimereki D. Muzaale;Allan B. Massie;Mei Cheng Wang;Robert A. Montgomery.
Perioperative mortality and long-term survival following live kidney donation.
Dorry L. Segev;Abimereki D. Muzaale;Brian S. Caffo;Shruti H. Mehta.
Sarcopenia and Mortality after Liver Transplantation
Michael J. Englesbe;Shaun P. Patel;Kevin He;Raymond J. Lynch.
Journal of The American College of Surgeons (2010)
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
M. Haas;A. Loupy;C. Lefaucheur;C. Roufosse.
American Journal of Transplantation (2018)
Desensitization in HLA-incompatible kidney recipients and survival.
Robert A. Montgomery;Bonnie E. Lonze;Karen E. King;Edward S. Kraus.
The New England Journal of Medicine (2011)
Kidney Paired Donation and Optimizing the Use of Live Donor Organs
Dorry L. Segev;Sommer E. Gentry;Daniel S. Warren;Brigitte Reeb.
A Nonsimultaneous, Extended, Altruistic-Donor Chain
Michael Kenneth Rees;Jonathan E. Kopke;Ronald P. Pelletier;Dorry L. Segev.
The New England Journal of Medicine (2009)
The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody‐Mediated Rejection
J. E. Locke;C. M. Magro;A. L. Singer;D. L. Segev.
American Journal of Transplantation (2008)
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.
Krista L. Lentine;Bertram L. Kasiske;Andrew S. Levey;Patricia L. Adams.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: